| Primary |
| Insomnia |
57.1% |
| Anxiety |
21.4% |
| Schizophrenia |
21.4% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
31.2% |
| Product Used For Unknown Indication |
25.9% |
| Bipolar I Disorder |
10.5% |
| Insomnia |
5.7% |
| Psychotic Disorder |
3.9% |
| Depression |
3.6% |
| Anxiety |
3.2% |
| Schizophrenia |
3.1% |
| Crohn's Disease |
1.7% |
| Psychiatric Symptom |
1.5% |
| Paranoia |
1.2% |
| Abnormal Behaviour |
1.1% |
| Agitation |
1.1% |
| Dysthymic Disorder |
1.1% |
| Foetal Exposure During Pregnancy |
1.1% |
| Atrial Fibrillation |
1.0% |
| Tuberculosis |
1.0% |
| Autism |
0.7% |
| Major Depression |
0.7% |
| Mental Disorder |
0.7% |
|
| Rhabdomyolysis |
10.0% |
| Vomiting |
10.0% |
| Suicide Attempt |
9.0% |
| Somnolence |
8.0% |
| Sepsis |
6.0% |
| Weight Decreased |
6.0% |
| Intra-uterine Death |
5.0% |
| Neuroleptic Malignant Syndrome |
5.0% |
| Fall |
4.0% |
| Lymphocytosis |
4.0% |
| Overdose |
4.0% |
| Respiratory Depression |
4.0% |
| Vaginitis Gardnerella |
4.0% |
| Ventricular Extrasystoles |
4.0% |
| Death |
3.0% |
| Extrapyramidal Disorder |
3.0% |
| Malaise |
3.0% |
| Pyrexia |
3.0% |
| Thrombocytopenia |
3.0% |
| Drug Toxicity |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.8% |
| Product Used For Unknown Indication |
20.4% |
| Depression |
9.9% |
| Insomnia |
5.3% |
| Bipolar I Disorder |
5.2% |
| Anxiety |
4.1% |
| Atrial Fibrillation |
3.9% |
| Schizophrenia |
3.5% |
| Hepatitis C |
3.3% |
| Pain |
2.9% |
| Bipolar Disorder |
2.7% |
| Hypertension |
2.4% |
| Hiv Infection |
2.3% |
| Psychotic Disorder |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Sleep Disorder |
1.9% |
| Blepharoplasty |
1.6% |
| General Anaesthesia |
1.6% |
| Metastatic Gastric Cancer |
1.6% |
| Pneumonia |
1.6% |
|
| Thrombocytopenia |
7.9% |
| Transaminases Increased |
7.9% |
| Cholestasis |
6.9% |
| Pyrexia |
6.9% |
| Renal Failure Acute |
6.9% |
| Cytolytic Hepatitis |
5.9% |
| Weight Increased |
5.9% |
| Overdose |
5.0% |
| Vomiting |
5.0% |
| White Blood Cell Count Increased |
5.0% |
| Hepatocellular Injury |
4.0% |
| Hyponatraemia |
4.0% |
| International Normalised Ratio Increased |
4.0% |
| Neutropenia |
4.0% |
| Rhabdomyolysis |
4.0% |
| Somnolence |
4.0% |
| Venoocclusive Liver Disease |
4.0% |
| Agranulocytosis |
3.0% |
| Inflammation |
3.0% |
| Intestinal Obstruction |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
38.9% |
| Bipolar I Disorder |
22.2% |
| Anxiety |
16.7% |
| Affective Disorder |
5.6% |
| Depression |
5.6% |
| Insomnia |
5.6% |
| Neuralgia |
5.6% |
|
| Muscular Weakness |
25.0% |
| Myalgia |
25.0% |
| Off Label Use |
25.0% |
| Rhabdomyolysis |
25.0% |
|
